Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial.
作者信息
Restelli Umberto, Fabbiani Massimiliano, Di Giambenedetto Simona, Nappi Carmela, Croce Davide
机构信息
Center for Health Economics, Social and Health Care Management, LIUC - Università Cattaneo, Castellanza, Italy.
School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
出版信息
Clinicoecon Outcomes Res. 2017 Sep 27;9:569-571. doi: 10.2147/CEOR.S143377. eCollection 2017.
Abstract
摘要
Zotero 插件